Autism spectrum disorder: Practice guidelines for pharmacists

Constantino JN Charman T. Diagnosis of autism spectrum disorder: reconciling the syndrome, its diverse origins, and variation in expression. Lancet Neurol 2016;15:279-91.

Lord C Elsabbagh M Baird G Veenstra-Vanderweele J. Autism spectrum disorder. Lancet 2018;392:508-20.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed., Text Revision (DSM-5-TR). Washington (DC): American Psychiatric Association; 2022.

Samsam M Ahangari R Naser SA. Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol 2014;20(29):9942-51.

Khanna R Jariwala K. Awareness and knowledge of autism among pharmacists. Res Social Adm Pharm 2012;8:464-71.

Hodges H Fealko C Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr 2020;9:S55-65.

Grove J Ripke S Als TD , et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet 2019;51:431-44.

Crowell JA Keluskar J Gorecki A. Parenting behavior and the development of children with autism spectrum disorder. Compr Psychiatry 2019;90:21-9.

Maenner M Shaw K Bakian A , et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2018. Surveill Summ 2021;70(11):1-16.

Public Health Agency of Canada. Autism spectrum disorder: Highlights from the 2019 Canadian health survey on children and youth. Ottawa (Canada): Public Health Agency of Canada; 2022.

Buescher AVS Cidav Z Knapp M Mandell DS . Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr 2014;168:721.

Hyman SL Levy SE Myers SM , et al. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics 2020;145(1):e20193447.

Ip A Zwaigenbaum L Brian JA. Post-diagnostic management and follow-up care for autism spectrum disorder. Paediatr Child Health 2019;24:461-77.

Taboas A Doepke K Zimmerman C. Preferences for identity-first versus person-first language in a US sample of autism stakeholders. Autism 2023;27:565-70.

Khanna R Jariwala K Holmes ER Ramachandran S. Autism familiarity and knowledge among pharmacy students. Curr Pharm Teach Learn 2014;6:150-7.

Knights E Sunderland B Parsons R Ziatas K Caccetta R. An evaluation of community pharmacists’ understanding of autism spectrum disorder: a cross-sectional study in Western Australia. Int J Pharm Pract 2020;28:41-8.

Leitner Y. The co-occurrence of autism and attention deficit hyperactivity disorder in children—What do we know? Front Hum Neurosci 2014;8:268.

Ghanizadeh A Molla MA Olango GJ. The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review. Neuropsychiatr Dis Treat 2019;15:1547-55.

Doyle CA McDougle CJ. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues Clin Neurosci 2012;14:263-79.

Sturman N Deckx L van Driel ML. Methylphenidate for children and adolescents with autism spectrum disorder. Cochrane Database Syst Rev 2017;11:CD011144.

Pearson DA Santos CW Aman MG , et al. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. J Child Adolesc Psychopharmacol 2013;23:337-51.

Ventura P de Giambattista C Spagnoletta L , et al. Methylphenidate in autism spectrum disorder: a long-term follow up naturalistic study. J Clin Med 2020;9:1-17.

Mayes SD Calhoun SL Murray MJ Ahuja M Smith LA. Anxiety, depression, and irritability in children with autism relative to other neuropsychiatric disorders and typical development. Res Autism Spectr Disord 2011;5:474-85.

Hartley SL Sikora DM McCoy R. Prevalence and risk factors of maladaptive behaviour in young children with autistic disorder. J Intellect Disabil Res 2008;52(10):819-29.

McCracken JT McGough J Shah B , et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002;347:314-21.

Levine SZ Kodesh A Goldberg Y , et al. Initial severity and efficacy of risperidone in autism: results from the RUPP trial. Eur Psychiatry 2016;32:16-20.

Hirsch LE Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2016;6:CD009043.

Kirino E. Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children. Clin Med Insights Pediatr 2014;8:17-30.

Menezes M Harkins C Robinson MF Mazurek MO. Treatment of depression in individuals with autism spectrum disorder: a systematic review. Res Autism Spectr Disord 2020;78:101639.

Hudson CC Hall L Harkness KL. Prevalence of depressive disorders in individuals with autism spectrum disorder: a meta-analysis. J Abnorm Child Psychol 2019;47:165-75.

Chandrasekhar T Sikich L. Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan. Dialogues Clin Neurosci 2015;17:219-27.

Kerns CM Kendall PC Zickgraf H Franklin ME Miller J Herrington J. Not to be overshadowed or overlooked: functional impairments associated with comorbid anxiety disorders in youth with ASD. Behav Ther 2015;46:29-39.

McCarty MJ Brumback AC. Rethinking stereotypies in autism. Semin Pediatr Neurol 2021;38:100897.

Soorya L Kiarashi J Hollander E. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 2008;17:753-71.

Morgan B Nageye F Masi G Cortese S. Sleep in adults with autism spectrum disorder: a systematic review and meta-analysis of subjective and objective studies. Sleep Med 2020;65:113-20.

Maglione MA Gans D Das L Timbie J Kasari C. Nonmedical interventions for children with ASD: recommended guidelines and further research needs. Pediatrics 2012;130:S169-78.

Boland R Verduin M Ruiz P. Kaplan & Sadock’s synopsis of psychiatry. 12th ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins (LWW); 2021.

Volkmar F Siegel M Woodbury-Smith M King B Mccracken J State M. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2014;53:237-57.

Nicolaidis C Raymaker DM Ashkenazy E , et al. “Respect the way I need to communicate with you”: healthcare experiences of adults on the autism spectrum. Autism 2015;19:824-31.

Zerbo O Massolo ML Qian Y Croen LA. A study of physician knowledge and experience with autism in adults in a large integrated healthcare system. J Autism Dev Disord 2015;45:4002-14.

Stahmer AC Vejnoska S Iadarola S , et al. Caregiver voices: cross-cultural input on improving access to autism services. J Racial Ethn Health Disparities 2019;6:752-73.

Strömberg M Liman L Bang P Igelström K. Experiences of sensory overload and communication barriers by autistic adults in health care settings. Autism Adulthood 2022;4:66-75.

Owen AM Gary A Schnetter V. Nursing care of patients with autism spectrum disorder. Nurs Made Incred Easy 2020;18:28-36.

Kasari C Brady N Lord C Tager-Flusberg H. Assessing the minimally verbal school-aged child with autism spectrum disorder. Autism Res 2013;6:479-93.

Cummins C Pellicano E Crane L. Autistic adults’ views of their communication skills and needs. Int J Lang Commun Disord 2020;55:678-89.

Bradshaw P Pickett C van Driel ML Brooker K Urbanowicz A. Recognising, supporting and understanding autistic adults in general practice settings. Aust J Gen Pract 2021;50:126-30.

Carroll SM. Respecting and empowering vulnerable populations: contemporary terminology. J Nurse Pract 2019;15:228-31.

Ho B Stephenson J Carter M. Anger in children with autism spectrum disorder: parent’s perspective. Int J Spec Educ 2012;27:14-32.

Tola G Talu V Congiu T Bain P Lindert J. Built environment design and people with autism spectrum disorder (Asd): a scoping review. Int J Environ Res Public Health 2021;18:1-14.